Five years ago there was little worth saying on the subject. Now we can state: Autoimmune chronic hepatitis can be effectively treated; chronic hepatitis B responds toα-interferon, as does chronic non-A, non-B hepatitis; colchicine is beneficial in primary biliary cirrhosis; and methotrexate seems even more promising in both that disease and primary sclerosing cholangitis.